Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review

2020 ◽  
Vol 56 ◽  
pp. 101505 ◽  
Author(s):  
Umme Hani ◽  
Mohamed Rahamathulla ◽  
Riyaz Ali Osmani ◽  
Honnavalli Yogish Kumar ◽  
Deeparani Urolagin ◽  
...  
F1000Research ◽  
2016 ◽  
Vol 5 ◽  
pp. 2782 ◽  
Author(s):  
Lisa O'Sullivan ◽  
Colin Buttimer ◽  
Olivia McAuliffe ◽  
Declan Bolton ◽  
Aidan Coffey

Bacteriophages (phages) are viruses that infect bacterial hosts, and since their discovery over a century ago they have been primarily exploited to control bacterial populations and to serve as tools in molecular biology. In this commentary, we highlight recent diverse advances in the field of phage research, going beyond bacterial control using whole phage, to areas including biocontrol using phage-derived enzybiotics, diagnostics, drug discovery, novel drug delivery systems and bionanotechnology.


2016 ◽  
Vol 17 (3) ◽  
pp. 337-352 ◽  
Author(s):  
Umme Hani ◽  
Riyaz Ali M. Osmani ◽  
Rohit R. Bhosale ◽  
Hosakote Gurumallappa Shivakumar ◽  
Parthasarathi K. Kulkarni

Author(s):  
Deep Shikha Sharma ◽  
Sheetu Wadhwa ◽  
Monica Gulati ◽  
Arya Kadukkattil Ramanunny ◽  
Ankit Awasthi ◽  
...  

Author(s):  
Umme Hani ◽  
Yogish Kumar Honnavalli ◽  
Yasmin Begum M ◽  
Sabina Yasmin ◽  
Riyaz Ali M. Osmani ◽  
...  

2013 ◽  
Vol 40 (10) ◽  
pp. 1014
Author(s):  
Xiao-Hong HAO ◽  
Cui-Miao ZHANG ◽  
Xiao-Long LIU ◽  
Xing-Jie LIANG ◽  
Guang JIA ◽  
...  

2020 ◽  
Vol 26 ◽  
Author(s):  
Ritu Mishra ◽  
Swati Gupta

Background: Rheumatoid arthritis (RA) is the most common occurring progressive, autoimmune disease, affecting 1% of the population and the ratio of affected women is three times as compared to men in most developing countries. Clinical manifestations of RA are the presence of anti-citrullinated protein antibody (ACPA) and rheumatoid factor (RF) in blood, tendered joints and soreness of the muscles. Some other factors which may lead to chronic inflammation are genetic and environmental factors as well as adaptive immune response. Several conventional drugs are available for the treatment of RA but have their own drawbacks which can be overcome by the use of novel drug delivery systems. : The objective of the present review is to focus on the molecular pathogenesis of the disease and its current conventional treatment with special reference to the role of novel drug delivery systems encapsulating anti rheumatic drugs and herbal drugs in passive and receptor mediated active targeting against RA. On reviewing the conventional and current therapeutics agains RA, we conclude that, although the current therapy for the treatment of RA is capable enough, yet more advances in the field of targeted drug delivery will sanguinely result in effective and appropriate treatment of this autoimmune disease.


2015 ◽  
Vol 16 (4) ◽  
pp. 344-364 ◽  
Author(s):  
Zerrin Bayindir ◽  
Nilufer Yuksel

Sign in / Sign up

Export Citation Format

Share Document